Almagate: Difference between revisions

Revision as of 20:16, 6 August 2011 editMcfer2k (talk \| contribs)9 editsmNo edit summary← Previous edit		Revision as of 20:27, 6 August 2011 edit undoCheMoBot (talk \| contribs)Bots141,565 edits Updating {{drugbox}} (no changed fields - added verified revid - updated 'DrugBank_Ref', 'ChEMBL_Ref', 'ChEBI_Ref', 'ChEBI_Ref') per Chem/Drugbox validation (report [[Misplaced Pages talk:WikiProject_PNext edit →
Line 1:		Line 1:
	{{drugbox		{{drugbox
		⚫	\| UNII_Ref = {{fdacite\|correct\|FDA}}
	\| Verifiedfields = changed
⚫	\| UNII_Ref = {{fdacite\|~~changed~~\|FDA}}
	\| UNII = 568Z59H7ZJ		\| UNII = 568Z59H7ZJ
	\| verifiedrevid = ~~399496073~~		\| verifiedrevid = 437148482
	\| IUPAC_name =		\| IUPAC_name =
	\| image = <!--Almagate.svg-->		\| image = <!--Almagate.svg-->
Line 17:		Line 16:
	\| ATC_suffix = AD03		\| ATC_suffix = AD03
	\| PubChem = 71749		\| PubChem = 71749
			\| DrugBank_Ref = {{drugbankcite\|correct\|drugbank}}
	\| DrugBank =		\| DrugBank =
	\| ChemSpiderID_Ref = {{chemspidercite\|correct\|chemspider}}		\| ChemSpiderID_Ref = {{chemspidercite\|correct\|chemspider}}
	\| ChemSpiderID = 64792		\| ChemSpiderID = 64792
	\| KEGG_Ref = {{keggcite\|~~changed~~\|kegg}}		\| KEGG_Ref = {{keggcite\|correct\|kegg}}
	\| KEGG = D02821		\| KEGG = D02821
	\| chemical_formula = Al<sub>2</sub>Mg<sub>6</sub>(OH)<sub>14</sub>(CO<sub>3</sub>)<sub>2</sub> · 4 H<sub>2</sub>O		\| chemical_formula = Al<sub>2</sub>Mg<sub>6</sub>(OH)<sub>14</sub>(CO<sub>3</sub>)<sub>2</sub> · 4 H<sub>2</sub>O

Revision as of 20:27, 6 August 2011

Pharmaceutical compound

Almagate
Clinical data
Routes of administration	Oral
ATC code	A02AD03 (WHO)
Identifiers
CAS Number	66827-12-1
PubChem CID	71749
ChemSpider	64792
UNII	568Z59H7ZJ
KEGG	D02821
CompTox Dashboard (EPA)	DTXSID30216935
Chemical and physical data
Formula	Al₂Mg₆(OH)₁₄(CO₃)₂ · 4 H₂O
Molar mass	314.99 g/mol
3D model (JSmol)	Interactive image
SMILES .......C()=O.....O.O
InChI InChI=1S/CH2O3.Al.3Mg.9H2O/c2-1(3)4;;;;;;;;;;;;;/h(H2,2,3,4);;;;;91H2/q;+3;3+2;;;;;;;;;/p-9 Key:MTEOMEWVDVPTNN-UHFFFAOYSA-E
(verify)

Almagate (trade name Almax) is an aluminium- and magnesium-containing antacid. It was first described in 1984.

Almagate is well tolerated. In a clinical trial, the most common adverse effects were diarrhea and nausea.

Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 6548918, please use {{cite journal}} with |pmid=6548918 instead.
Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 6439224, please use {{cite journal}} with |pmid=6439224 instead.
Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 6548926, please use {{cite journal}} with |pmid=6548926 instead.

v t e Drugs for acid related disorders: Antacids (A02A)
Magnesium (increases motility)	Magnesium carbonate Magnesium oxide Magnesium peroxide Magnesium hydroxide Magnesium silicate
Aluminium (decreases motility)	Aceglutamide aluminum Algeldrate Aluminium phosphate Aluminium acetoacetate Aloglutamol Aluminium glycinate Carbaldrate
Calcium	Calcium carbonate Calcium silicate
Sodium	Sodium bicarbonate
Combinations and complexes of aluminium, calcium and magnesium	Almagate Almasilate Hydrotalcite Magaldrate

This drug article relating to the gastrointestinal system is a stub. You can help Misplaced Pages by expanding it.